Colorectal cancer screening and subsequent incidence of colorectal cancer: Results from the 45 and Up Study

Medical Journal of Australia

Volumn 201, Issue 9, 2014, Pages 523-527

  Steffen, Annika ^a   Weber, Marianne F ^b   Roder, David M ^a   Banks, Emily ^c  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b CANCER RESEARCH DIVISION   (Australia)

^c The Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASCENDING COLON; AUSTRALIA; CANCER SCREENING; COLORECTAL CANCER; DESCENDING COLON; ENDOSCOPY; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PROSPECTIVE STUDY; QUESTIONNAIRE; RECTUM; RECTUM CANCER; SMOKING; COLONOSCOPY; COLORECTAL NEOPLASMS; EPIDEMIOLOGY; INCIDENCE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; RISK REDUCTION; STATISTICS AND NUMERICAL DATA;

AUSTRALIA; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK REDUCTION BEHAVIOR; SMOKING;

EID: 84908406982     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja14.00197     Document Type: Article

References (30)

1. Australian Institute of Health and Welfare. Australian Cancer Incidence and Mortality (ACIM) books. Canberra: AIHW, 201 1. http:// www.aihw.gov.au/acim-books (accessed Jul 2014).
2. Hewitson P, Glasziou P, Irwig L, et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007; (1): CD001216.
3. Elmunzer BJ, Hayward RA, Schoenfeld PS, et al. Eff ect of fl exible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLOS Med 2012; 9: e1001352.
4. Australian Institute of Health and Welfare. National Bowel Cancer Screening Program monitoring report: phase 2, July 2008 - June 2011. Canberra: AIHW, 2012. (AIHW Cat. No. CAN 62; Cancer Series No. 66.) http://www.aihw. gov.au/publication-detail/?id=10737421408 (accessed Jul 2014).
5. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-1595.
6. von Karsa L, Anttila A, Ronco G, et al. Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening. Lyon: International Agency for Research on Cancer, 200 8. http://ec.europa.eu/health/ ph_determinants/genetics/documents/ cancer_screening.pdf (accessed Jul 2014).
7. Australian Cancer Network Colorectal Cancer Guidelines Revision Committee. Guidelines for the prevention, early detection and management of colorectal cancer. Sydney: Cancer Council Australia and Australian Cancer Network, 2005. http://www.nhmrc.gov.au/ guidelines/publications/cp106 (accessed Jul 2014).
8. Ananda SS, McLaughlin SJ, Chen F, et al. Initial impact of Australia's National Bowel Cancer Screening Program. Med J Aust 2009; 191: 378-381.
9. Cole SR, Tucker GR, Osborne JM, et al. Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening Program. Med J Aust 2013; 198: 327-330.
10. Kavanagh AM, Giovannucci EL, Fuchs CS, Colditz GA. Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control 1998; 9: 455-462.
11. Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 2013; 369: 1095-1105.
12. 45 and Up Study Collaborators, Banks E, Redman S, et al. Cohort profile: the 45 and Up Study. Int J Epidemiol 2008; 37: 941-947.
13. Sax Institute. 45 and Up Study technical note 1: Missing or invalid values. 2013. https://www. saxinstitute.org.au/wp-content/uploads/ Technical-Note-missing-or-invalid-values.pdf (accessed Jun 2014).
14. Sax Institute. The baseline questionnaire. https://www.saxinstitute.org.au/our-work/45- up-study/questionnaires (accessed Jun 2014).
15. Kemp A, Preen DB, Saunders C, et al. Ascertaining invasive breast cancer cases; the validity of administrative and self-reported data sources in Australia. BMC Med Res Methodol 2013; 13: 17.
16. Goldsbury DE, Armstrong K, Simonella L, et al. Using administrative health data to describe colorectal and lung cancer care in New South Wales, Australia: a validation study. BMC Health Serv Res 2012; 12: 387.
17. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009; 338: b2393.
18. Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update. Am J Gastroenterol 2008; 103: 1541-1549.
19. Kronborg O, Jørgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol 2004; 39: 846-851.
20. Bretthauer M, Kalager M. Principles, eff ectiveness and caveats in screening for cancer. Br J Surg 2013; 100: 55-65.
21. Brenner H, Hoff meister M, Arndt V, et al. Protection from right- and left-sided colorectal neoplasms after colonoscopy: populationbased study. J Natl Cancer Inst 2010; 102: 89-95.
22. Cotterchio M, Manno M, Klar N, et al. Colorectal screening is associated with reduced colorectal cancer risk: a case-control study within the population-based Ontario Familial Colorectal Cancer Registry. Cancer Causes Control 2005; 16: 865-875.
23. Lieberman DA. Clinical practice. Screening for colorectal cancer. N Engl J Med 2009; 361: 1179-1187.
24. Kaminski MF, Bretthauer M, Zauber AG, et al. The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy 2012; 44: 695-702.
25. Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012; 366: 697-706.
26. Haug U, Knudsen AB, Brenner H, Kuntz KM. Is fecal occult blood testing more sensitive for left- versus right-sided colorectal neoplasia? A systematic literature review. Expert Rev Mol Diagn 2011; 11: 605-616.
27. Whitlock EP, Lin J, Liles E, et al. Screening for colorectal cancer: an updated systematic review. Rockville, Md: Agency for Healthcare Research and Quality, 2008.
28. Brenner H, Arndt V, Stürmer T, et al. Longlasting reduction of risk of colorectal cancer following screening endoscopy. Br J Cancer 2001; 85: 972-976.
29. Newcomb PA, Storer BE, Morimoto LM, et al. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst 2003; 95: 622-625.
30. Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008; 17: 748-757.